Literature DB >> 26691418

Mobilization policy in multiple myeloma: minimum target or law of redundancy? Two different approaches by the two sides of the Atlantic Ocean.

A Olivieri1, F Saraceni1.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26691418     DOI： 10.1038/bmt.2015.317

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  20 in total

Review 1.  Mobilized peripheral blood grafts include more than hematopoietic stem cells: the immunological perspective.

Authors:  F Saraceni; N Shem-Tov; A Olivieri; A Nagler
Journal:  Bone Marrow Transplant       Date:  2015-02-09       Impact factor: 5.483

2.  Autologous transplantation and maintenance therapy in multiple myeloma.

Authors:  Antonio Palumbo; Federica Cavallo; Francesca Gay; Francesco Di Raimondo; Dina Ben Yehuda; Maria Teresa Petrucci; Sara Pezzatti; Tommaso Caravita; Chiara Cerrato; Elena Ribakovsky; Mariella Genuardi; Anna Cafro; Magda Marcatti; Lucio Catalano; Massimo Offidani; Angelo Michele Carella; Elena Zamagni; Francesca Patriarca; Pellegrino Musto; Andrea Evangelista; Giovannino Ciccone; Paola Omedé; Claudia Crippa; Paolo Corradini; Arnon Nagler; Mario Boccadoro; Michele Cavo
Journal:  N Engl J Med       Date:  2014-09-04       Impact factor: 91.245

3.  Comparison of high-dose CY and growth factor with growth factor alone for mobilization of stem cells for transplantation in patients with multiple myeloma.

Authors:  M A Gertz; S K Kumar; M Q Lacy; A Dispenzieri; S R Hayman; F K Buadi; D Dingli; D A Gastineau; J L Winters; M R Litzow
Journal:  Bone Marrow Transplant       Date:  2008-11-10       Impact factor: 5.483

4.  Plerixafor and granulocyte colony-stimulating factor for first-line steady-state autologous peripheral blood stem cell mobilization in lymphoma and multiple myeloma: results of the prospective PREDICT trial.

Authors:  Nigel Russell; Kenny Douglas; Anthony D Ho; Mohamad Mohty; Kristina Carlson; G J Ossenkoppele; Giuseppe Milone; Macarena Ortiz Pareja; Daniel Shaheen; Arnold Willemsen; Nicky Whitaker; Christian Chabannon
Journal:  Haematologica       Date:  2012-09-14       Impact factor: 9.941

5.  Stem cell mobilization with cyclophosphamide overcomes the suppressive effect of lenalidomide therapy on stem cell collection in multiple myeloma.

Authors:  Tomer Mark; Jessica Stern; Jessica R Furst; David Jayabalan; Faiza Zafar; April LaRow; Roger N Pearse; John Harpel; Tsiporah Shore; Michael W Schuster; John P Leonard; Paul J Christos; Morton Coleman; Ruben Niesvizky
Journal:  Biol Blood Marrow Transplant       Date:  2008-07       Impact factor: 5.742

6.  Plerixafor (Mozobil): A Stem Cell-Mobilizing Agent for Transplantation in Lymphoma Patients Predicted to Be Poor Mobilizers - A Pilot Study.

Authors:  Ivetta Danylesko; Rina Sareli; Nira Varda-Bloom; Ronit Yerushalmi; Noga Shem-Tov; Avichai Shimoni; Arnon Nagler
Journal:  Acta Haematol       Date:  2015-08-22       Impact factor: 2.195

Review 7.  Optimizing autologous stem cell mobilization strategies to improve patient outcomes: consensus guidelines and recommendations.

Authors:  Sergio Giralt; Luciano Costa; Jeffrey Schriber; John Dipersio; Richard Maziarz; John McCarty; Paul Shaughnessy; Edward Snyder; William Bensinger; Edward Copelan; Chitra Hosing; Robert Negrin; Finn Bo Petersen; Damiano Rondelli; Robert Soiffer; Helen Leather; Amy Pazzalia; Steven Devine
Journal:  Biol Blood Marrow Transplant       Date:  2013-10-17       Impact factor: 5.742

8.  Low-dose or intermediate-dose cyclophosphamide plus granulocyte colony-stimulating factor for progenitor cell mobilisation in patients with multiple myeloma.

Authors:  E Jantunen; M Putkonen; T Nousiainen; T-T Pelliniemi; E Mahlamäki; K Remes
Journal:  Bone Marrow Transplant       Date:  2003-03       Impact factor: 5.483

9.  Hematopoietic SCT in Europe 2013: recent trends in the use of alternative donors showing more haploidentical donors but fewer cord blood transplants.

Authors:  J R Passweg; H Baldomero; P Bader; C Bonini; S Cesaro; P Dreger; R F Duarte; C Dufour; J H F Falkenburg; D Farge-Bancel; A Gennery; N Kröger; F Lanza; A Nagler; A Sureda; M Mohty
Journal:  Bone Marrow Transplant       Date:  2015-02-02       Impact factor: 5.483

10.  Contribution of chemotherapy mobilization to disease control in multiple myeloma treated with autologous hematopoietic cell transplantation.

Authors:  G L Uy; L J Costa; P N Hari; M-J Zhang; J-X Huang; K C Anderson; C N Bredeson; N S Callander; R F Cornell; M A D Perez; A Dispenzieri; C O Freytes; R P Gale; A Garfall; M A Gertz; J Gibson; M Hamadani; H M Lazarus; M E Kalaycio; R T Kamble; M A Kharfan-Dabaja; A Y Krishnan; S K Kumar; R A Kyle; H J Landau; C H Lee; A Maiolino; D I Marks; T M Mark; R Munker; T Nishihori; R F Olsson; M Ramanathan; T E Rodriguez; A A Saad; B N Savani; G J Schiller; H C Schouten; J R Schriber; E Scott; S Seo; M Sharma; S Ganguly; E A Stadtmauer; J Tay; L B To; D H Vesole; D T Vogl; J L Wagner; B Wirk; W A Wood; A D'Souza
Journal:  Bone Marrow Transplant       Date:  2015-08-24       Impact factor: 5.483
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.